Netmore Group Appoints Jon Ullmark as Executive Vice President, North America
Netmore Group, a leading global LoRaWAN network operator, today announced it has named Jon Ullmark as Executive Vice President, North America. Jon brings extensive business and product leadership to Netmore, with experience across Cloud Native, Wireless/IoT, 5G/Private and applied AI/ML technologies within telecommunications and IT focused organizations. In this role, Jon will oversee commercial activities and growth strategies across North America, including business development in the United States following Netmore’s recent acquisition of LoRaWAN network operator Senet.
With experience managing and scaling products, teams, and partnerships at both smaller entrepreneurial companies and larger organizations, Jon joins Netmore from Ranplan Wireless where he held the position of Chief Strategy Officer. Prior to Ranplan, Jon held General Manager and senior executive roles at business-to-business software and services companies delivering engineering expertise, digital services, and sustainability practices.
“It is an exciting time to be joining Netmore as the company expands its offerings and service delivery footprint to help drive innovation and efficiency into several areas of industry and critical infrastructure. I look forward to collaborating throughout the organization and the market ecosystem to remove barriers to entry, drive scale, and deliver on the needs of customers,” said Jon Ullmark.
In addition to expanding the company’s Network-as-a-Service delivery to utilities, IoT application providers and device manufacturers, Ullmark will focus on expanding strategic partnerships and executing go-to-market strategies for Netmore’s Platform-as-a-Service offering which provides enterprises, municipalities, system integrators, and network operators with cloud-based services needed to plan, build, and operate their own LoRaWAN networks.
“The North American market represents a tremendous opportunity for Netmore, as a healthy combination of organic growth and smart industry regulation is driving the adoption of both public and owner-operated Low Power Wide Area Networks services. As we focus on solving some of the longstanding challenges of fragmented solution offerings and scale through our customer focused growth initiatives, Jon is well suited to cement our position as a market disruptor,” said Ove Anebygd, CEO Netmore Group AB.
To learn more about Netmore’s cloud-based connectivity platforms and network coverage, contact info@netmoregroup.com.
Netmore Group is an IoT network operator, building the leading multinational network to advance sustainable business practices. We offer a reliable network platform and leading connectivity expertise for efficient measuring, monitoring, and optimisation of resource use. With 10 years in the industry, we have a solid track record, operating borderless on the European market and have grown to become a leading global network operator. Netmore group’s main owner is the Nordic infrastructure investor Polar Structure.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240529557268/en/
Contact information
Media Contact:
James Gerber
Crackle Communications
+1 508-233-3391
netmore@cracklepr.com
Netmore Contact:
Ken Lynch
VP, Global Marketing
+1 617-877-5393
ken.lynch@netmoregroup.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeiGene Highlights Innovative Hematology Portfolio Across B-cell Malignancies at ASH 20245.11.2024 15:05:00 CET | Press Release
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will share new data across a range of B-cell malignancies and assets, including best-in-class Bruton’s tyrosine kinase (BTK) inhibitor BRUKINSA® (zanubrutinib), at the 66th ASH Annual Meeting and Exposition in San Diego, December 7-10. BeiGene has 21 abstracts accepted at ASH 2024, with four selected for oral presentation. “In the five years since its initial approval, BRUKINSA has become a standard of care for patients facing many B-cell malignancies, and our data featured at ASH demonstrated how long-term follow-up of treatment with BRUKINSA elicited deep and durable responses, including in patients with chronic lymphocytic leukemia and Waldenström’s macroglobulinemia,” said Mehrdad Mobasher, M.D., M.P.H., Chief Medical Officer, Hematology at BeiGene. “BRUKINSA is just the starting point – pipeline data for our BTK degrader BGB-16673 and BCL2 inhibitor sonrotoclax showcase our contin
DirectSens’ Market-Leading LactoSens ® Biosensor Technology Acquired by Kerry Group P.L.C.5.11.2024 14:00:00 CET | Press Release
DirectSens, a pioneer in next generation biosensor technology, announces the acquisition of its LactoSens® technology by Kerry Group, a global leader in taste and nutrition. The acquisition of LactoSens® reflects DirectSens’ success in developing end-to-end biosensor solutions and represents a move by Kerry Group to complement its offering in lactase enzymes. As an indispensable analytical tool, LactoSens® will work alongside Kerry Group’s ingredient solutions, enabling a more integrated offering for food manufacturers. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241105399369/en/ LactoSens®, Industry Gold Standard Biosensor Kit. Developed and manufactured by DirectSens in Vienna, AUSTRIA, © DirectSens GmbH 2024 “We’re excited to bring LactoSens® into Kerry Group’s portfolio to add a new element to our offering, as we fully integrate LactoSens® into our broader solutions for the food and beverage industry.” — Ronan Moloney
Technology Holdings Has Expanded Operations into Brazil, Driving Growth in Latin America5.11.2024 13:35:00 CET | Press Release
Technology Holdings (TH), an award-winning global boutique investment bank with a track record of closing transactions in 24 countries, proudly announces its strategic expansion into Brazil, leveraging digital transformation within one of Latin America’s largest economies. This move significantly strengthens Technology Holdings’ presence in the rapidly growing Latin American market, enabling the firm to play a vital role in the region's expanding M&A landscape. According to Dealogic, M&A deals totaling $35 billion have been announced, reflecting a 56% increase compared to the same period last year. As companies increasingly look to consolidate and expand, Technology Holdings is uniquely positioned to provide strategic guidance and facilitate successful transactions. “The expansion into Brazil represents an exciting opportunity for us to deepen our relationships within this vibrant market,” said Edoardo Freschet, Head of Latin America at Technology Holdings. “The quality of talent and t
EUMETSAT: Lisbon Event Offers a Deep Dive Into Ocean Data5.11.2024 13:07:00 CET | Press Release
People with an interest in our oceans – from academics to businesspeople through to representatives from navies and weather services – are meeting in Lisbon, Portugal, for a deep dive into satellite data and its uses. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241105106009/en/ (Photo: Business Wire) Europe’s meteorological satellite agency, EUMETSAT, the European Commission, the European Space Agency, the European Centre for Medium-Range Weather Forecasts and Mercator Ocean International are hosting the two-day event starting today. The aim is to showcase how data from the Copernicus Sentinel satellites are used to benefit agencies and businesses with an interest in the marine environment, to connect data users with different skills and expertise, and to receive feedback on how to better meet the needs of existing and potential data users. “What happens in our oceans influences everyone’s lives by impacting our weather,
Delta-Fly Pharma Inc.: Update for Expanded Phase I Study of DFP-149275.11.2024 12:00:00 CET | Press Release
We are excited to share our latest development status. As informed dated October 28th, an interim analysis for the Phase III study ofDFP-10917 in R/R AML patients is ongoing. The Phase I/II combination study of DFP-10917 with Venetoclax in AML patients is well ongoing. Today, we are delighted to talk about an update for development of the drug delivery of DFP-10917 selective to solid tumor, which is namely, DFP-14927 showed nice safety and efficacy in the Phase I study in solid tumor patients. Accordingly, we have moved forward into an expanded Phase I study of DFP-14927 at 3200 mg/m2 weekly dosing in R/R colorectal cancer patients at MD Anderson Cancer Center and UCLA. Efficacy in expanded Phase I study is evaluated by Disease Control Ratio (DCR) and it shall be evaluated by OS in the next registration study for NDA approval. View source version on businesswire.com: https://www.businesswire.com/news/home/20241105884234/en/
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom